153 related articles for article (PubMed ID: 2582468)
21. Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.
Stone RM; DeAngelo DJ; Janosova A; Galinsky I; Canning C; Ritz J; Soiffer RJ
Am J Hematol; 2008 Oct; 83(10):771-7. PubMed ID: 18756547
[TBL] [Abstract][Full Text] [Related]
22. Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes.
Invernizzi R; Pecci A; Rossi G; Pelizzari AM; Giusto M; Tinelli C; Ascari E
Haematologica; 1997; 82(5 Suppl):9-12. PubMed ID: 9402747
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
Malpas J; Mathé G; Hayat M
Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
[No Abstract] [Full Text] [Related]
24. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
[TBL] [Abstract][Full Text] [Related]
25. [Low-dose cytosine arabinoside (ARA-C) in the treatment of acute myeloid leukemia].
Beris P; Rieder A; Andrey C; Helg C; Chapuis B
Schweiz Med Wochenschr; 1984 Dec; 114(48):1763-6. PubMed ID: 6596706
[TBL] [Abstract][Full Text] [Related]
26. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
[TBL] [Abstract][Full Text] [Related]
27. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
[TBL] [Abstract][Full Text] [Related]
28. Consolidation therapy without maintenance for acute non-lymphoblastic leukaemia.
Roberts MM; Juttner CA; Blunden RW; Horvath N; To LB; Ho JQ; Dart GW; Kimber RJ
Med J Aust; 1988 Feb; 148(4):181-3. PubMed ID: 3340044
[TBL] [Abstract][Full Text] [Related]
29. rHuGM-CSF after high-dose chemotherapy in post-remission acute leukemia.
Hurtado R; Candelaria M; Vargas F; Majluf A; Bolaños F; Labardini JR
Stem Cells; 1995 Mar; 13(2):112-22. PubMed ID: 7787778
[TBL] [Abstract][Full Text] [Related]
30. Jaundice following high--dose arabinoside cytosine in a child with acute myelogenous leukemia.
Wysocki M; Nowaczyk-Michalak A; Pilecki O; Trybuś L; Balcar-Boroń A
Acta Haematol Pol; 1992; 23(3):197-9. PubMed ID: 1492544
[TBL] [Abstract][Full Text] [Related]
31. [Letter: High remission rate in acute myeloid leukemia (AML) by adriamycin, vincristine and cytosine arabinoside combination. Importance of intensive hematological care].
Mathé G; Pouillart P; De Vassal F; Delgado M; Schwarzenberg L; Misset JL; Hayat M
Nouv Presse Med; 1976 Aug 28-Sep 4; 5(28):1758. PubMed ID: 1066659
[No Abstract] [Full Text] [Related]
32. [Clinical use of cytosine arabinoside in childhood. II. Cytosine arabinoside in the prevention and therapy of leukemic meningosis].
Masi M; Paolucci P; Vivarelli F; Vecchi V
Minerva Pediatr; 1975 Sep; 27(30):1624-31. PubMed ID: 1058332
[No Abstract] [Full Text] [Related]
33. [Treatment of acute myeloid leukaemia in adults with cytarabine and thioguanine].
Fülle HH; Pribilla W
Dtsch Med Wochenschr; 1972 May; 97(18):711-7. PubMed ID: 4502483
[No Abstract] [Full Text] [Related]
34. Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytosine arabinoside: a case report.
Pellier I; Leboucher B; Rachieru P; Ifrah N; Rialland X
J Pediatr Hematol Oncol; 2006 Dec; 28(12):837-9. PubMed ID: 17164656
[TBL] [Abstract][Full Text] [Related]
35. Low-dose cytosine arabinoside in acute non-lymphoblastic leukemia.
Kumar L; Kochupillai V; Dua H
Cancer; 1989 Feb; 63(3):415-8. PubMed ID: 2912519
[TBL] [Abstract][Full Text] [Related]
36. Cytosine arabinoside as a single agent in the therapy of adult acute leukemia.
Armentrout SA; Burns CP
Am J Med Sci; 1974 Sep; 268(3):163-8. PubMed ID: 4531223
[No Abstract] [Full Text] [Related]
37. Epirubicin and cytosine arabinoside for the induction therapy of childhood acute nonlymphocytic leukemia.
Liang DC; Jiang CJ
Am J Hematol; 1991 Dec; 38(4):267-70. PubMed ID: 1746534
[TBL] [Abstract][Full Text] [Related]
38. Prolonged maintained remissions of adult acute non-lymphocytic leukaemia.
Peterson BA; Bloomfield CD
Lancet; 1977 Jul; 2(8030):158-60. PubMed ID: 69780
[TBL] [Abstract][Full Text] [Related]
39. ["Small doses" of cytosar in the therapy of acute nonlymphoblastic leukemias].
Kucher RA; Isaev VG; Savchenko VG
Ter Arkh; 1992; 64(7):21-4. PubMed ID: 1440360
[No Abstract] [Full Text] [Related]
40. [Acute promyelocytic leukemia: confirmation of the therapeutic value of the cytosine arabinoside-thioguanine combination].
Monica C; Cucinotta D; Carapezzi C; Ceccato S
G Clin Med; 1976; 57(5-6):192-9. PubMed ID: 1070455
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
